Estimating benefit from dose dense adjuvant chemotherapy for early breast cancer in the PANTHER randomized phase 3 trial

被引：0
|
作者：
Matikas, Alexios
Gnant, Michael
Johansson, Hemming
Untch, Michael
Tsiknakis, Nikolaos
Greil, Richard
Loibl, Sibylle
Foukakis, Theodoros
Bergh, Jonas C. S.
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
[4] Helios Klinikum Berlin Buch, Berlin, Germany
[5] Paracelsus Med Univ, Canc Cluster Salzburg, Ctr Clin Canc & Immunol Trials, Med Dept 3,Salzburg Canc Res Inst, Salzburg, Austria
[6] GBG Forsch GmbH, Neu Isenburg, Germany
[7] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[8] Karolinska Univ Hosp, Karolinska Comprehens Canc Ctr, Breast Canc Ctr, Canc Theme, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
521
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer
    Criscitiello, Carmen
    Viale, Giulia
    Curigliano, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 472 - 479
  • [32] ADJUVANT CHEMOTHERAPY - THE RESULTS OF A RANDOMIZED TRIAL IN BREAST-CANCER
    STEWART, HJ
    FORREST, APM
    RODGER, A
    DUNCAN, W
    LANGLANDS, AO
    GUNN, JM
    SONGHORABADI, S
    BRITISH JOURNAL OF SURGERY, 1983, 70 (11) : 687 - 687
  • [33] PROGNOSTIC TOOLS IN EARLY BREAST CANCER: PREDICTING BENEFIT OF ADJUVANT CHEMOTHERAPY
    Parkes, E. E.
    Davidson, C.
    Hussain, A.
    James, C. R.
    Hanna, G. G.
    ANNALS OF ONCOLOGY, 2012, 23 : 107 - 107
  • [34] Prognostic Tools in Early Breast Cancer: Predicting benefit of adjuvant chemotherapy
    Parkes, E. E.
    Davidson, C.
    James, C. R.
    Hanna, G. G.
    CANCER RESEARCH, 2012, 72
  • [35] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    A. Sverrisdottir
    M. Nystedt
    H. Johansson
    T. Fornander
    Breast Cancer Research and Treatment, 2009, 117
  • [36] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    Sverrisdottir, A.
    Nystedt, M.
    Johansson, H.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 561 - 567
  • [37] Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
    Arriagada, R
    Lê, MG
    Spielmann, M
    Mauriac, L
    Bonneterre, J
    Namer, M
    Delozier, T
    Hill, C
    Tursz, T
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 389 - 396
  • [38] Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials
    Fausto Petrelli
    Mary Cabiddu
    Andrea Coinu
    Karen Borgonovo
    Mara Ghilardi
    Veronica Lonati
    Sandro Barni
    Breast Cancer Research and Treatment, 2015, 151 : 251 - 259
  • [39] Adjuvant dose-dense chemotherapy in breast cancer: a systematic review and meta-analysis of randomized trials
    Petrelli, Fausto
    Cabiddu, Mary
    Coinu, Andrea
    Borgonovo, Karen
    Ghilardi, Mara
    Lonati, Veronica
    Barni, Sandro
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (02) : 251 - 259
  • [40] Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial
    Amelie de Gregorio
    Lothar Häberle
    Peter A. Fasching
    Volkmar Müller
    Iris Schrader
    Ralf Lorenz
    Helmut Forstbauer
    Thomas W. P. Friedl
    Emanuel Bauer
    Nikolaus de Gregorio
    Miriam Deniz
    Visnja Fink
    Inga Bekes
    Ulrich Andergassen
    Andreas Schneeweiss
    Hans Tesch
    Sven Mahner
    Sara Y. Brucker
    Jens-Uwe Blohmer
    Tanja N. Fehm
    Georg Heinrich
    Krisztian Lato
    Matthias W. Beckmann
    Brigitte Rack
    Wolfgang Janni
    Breast Cancer Research, 22
12345